AGA issues new guidance for IBD management during COVID-19 pandemic

The American Gastroenterological Association issued new guidance for the clinical management of patients with inflammatory bowel disease during the COVID-19 pandemic.“While the COVID-19 pandemic is a global health emergency, patients with IBD have particular concerns for their risk for infection and management of their medical therapies,” the AGA said in a release. “This clinical practice update incorporates the emerging understanding of COVID-19 and summarizes available guidance for patients with IBD and the providers who take care of them.”In the expert commentary,Read More

Share on facebook
Share on twitter
Share on linkedin